logo

For the Inventor, By the Inventor

Carros, France

Virbac Corporation


USPTO Granted Patents = 48

% Expired Patents = 12.5



Trademarks = 63

Forward Citations = 208

Loading Chart...
Loading Chart...

71 inventors (with patents filed for the assignee):

goldMedal Guy Derrieu (8 out of 22 patents)

silverMedal Michel Robin (7 out of 7 patents)

bronzeMedal Thomas A Miller (4 out of 4 patents)

4.  Laurent Rodrigues (3 out of 3 patents)

5.  Arnaud Steiner (3 out of 3 patents)

6.  Patricia Monginoux (3 out of 3 patents)

7.  Fanny Martins (3 out of 3 patents)

8.  Nathalie Delhom (3 out of 3 patents)

9.  Bertrand Havrileck (3 out of 4 patents)

10.  Albert Ahn (3 out of 14 patents)

11.  Ian Cottrell (3 out of 21 patents)

12.  Benoît Berny (2 out of 2 patents)

13.  Jean-Michel Brunel (2 out of 8 patents)

14.  Jean-Pascal Marc (2 out of 2 patents)

15.  Nicolas Brunel (2 out of 2 patents)


Core Competencies:
Fluralaner
Modoflaner
Glucocorticoids
Anxiety Treatment
Anthelmintic Formulations
Topical Compositions
Veterinary Use
Squalamine Derivatives
Vaccine Composition
Behavioral Disorders
Nutritional Composition
Parasite Control

48 patents:

1. 12714696 - Low dose fluralaner compositions for protection against parasitic invertebrate pest (2026-08-25),
2. 12509425 - Tablet comprising modoflaner as an active component (2025-12-30),
3. 12478629 - Use of glucocorticoids for the treatment of epithelial microbial infections of a fluid containing organ with a natural exterior orifice in mammals (2025-11-25),
4. 11819506 - Use of glucocorticoids for the treatment of epithelial microbial infections of a fluid containing organ with a natural exterior orifice in mammals (2023-11-21),
5. 11752127 - Methods and compositions for treatment of anxiety in animals (2023-09-12),
6. 11628973 - Impact-protection device capable of being provided on a bottle (2023-04-18),
7. 11364175 - Device for collecting a sample of a liquid contained in a container, associated container, and use of this container (2022-06-21),
8. 11325748 - Impact-protection device capable of being provided on a bottle (2022-05-10),
9. 11266789 - Multi-dose dispenser (2022-03-08),
10. 10780101 - Amide derivatives of squalamine for the treatment of infections (2020-09-22),
11. 10729701 - Compounds that are analogs of squalamine, used as antibacterial agents (2020-08-04),
12. D878214 - Bottle protector (2020-03-17),
13. 10548867 - Soothing composition for animals, comprising at least one fatty acid and nepetalactone (2020-02-04),
14. 10493032 - Nutritional and medicinal oral composition for veterinary use (2019-12-03),
15. 10426840 - Oil suspension of metronidazole (2019-10-01),
Virbac Corporation is a global leader in veterinary pharmaceuticals, dedicated to improving animal health through innovative solutions. Headquartered in Carros, France, the company specializes in a diverse range of products, including glucocorticoids, topical compositions, and sustained release vaccines. Virbac's research focuses on addressing various veterinary needs, such as epithelial infections, anthelmintic formulations, and behavioral disorders, ensuring comprehensive care for animals worldwide.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Virbac Corporation
48 Patents

#1 in Carros

#489 in France

#14,536 in the World

Carros, FR
Carros, France

Virbac Corporation

Forward Citations = 208

71 inventors:

goldMedal Guy Derrieu (8 out of 22 patents)

silverMedal Michel Robin (7 out of 7 patents)

bronzeMedal Thomas A Miller (4 out of 4 patents)

4.  Laurent Rodrigues (3 out of 3 patents)

5.  Arnaud Steiner (3 out of 3 patents)

Please report any incorrect information to [email protected]
Loading…